Alcon AG (ALC)
72.04
-0.20
(-0.28%)
USD |
NYSE |
Sep 03, 16:00
72.04
0.00 (0.00%)
After-Hours: 20:00
Alcon Research and Development Expense (Annual) : 990.00M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 990.00M |
| December 31, 2024 | 876.00M |
| December 31, 2023 | 828.00M |
| December 31, 2022 | 702.00M |
| December 31, 2021 | 653.00M |
| December 31, 2020 | 592.00M |
| Date | Value |
|---|---|
| December 31, 2019 | 619.00M |
| December 31, 2018 | 587.00M |
| December 31, 2017 | 584.00M |
| December 31, 2016 | 499.00M |
| December 31, 2015 | 458.00M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Globus Medical, Inc. | 146.94M |
| Metall Zug AG | 31.41M |
| Ypsomed Holding AG | 49.86M |
| Straumann Holding AG | -- |
| Medacta Group SA | 14.54M |